Kindeva

Our lab is efficiently run with currently little to no lead time. Some of the common testing services we can support out of our Woodbury, MN state-of-the-art laboratory are: • Method and Validation for clinical stage • Extractables and Leachables • Stability and storage • Container Closure Integrity Test...

Microneedle Technology: Development, clinical and commercial scale up. Potential room temperature stability, avoiding needle stick, easy to administer. Transdermal: Single-layer drug-in adhesive patches  Multi-layer drug-in adhesive patches  Active gel patch formulation (applied as a gel, dries to discre...

Early-stage device selection and formulation design through all stages of product testing and process development, cGMP scale-up, and commercialization 

From formulation development to commercial distribution in the US, 10 countries in Europe, and Australia 55,000 ft² (5,100 m²) of space on the Coldstream Research Campus in Lexington FDA/EMA-approved nasal spray production facility DEA-registered to manufacture and test controlled substances

Commercial and Clinical. State of the Art, fully Annex 1 compliant facility, 60 years of experience Four Isolator lines with infrastructure in place for up to eight lines 200,000 sq. ft. cGMP footprint 100M+ unit capacity across Vial, Syringes, and Cartridges Sterile injectable Fill/Finish and final assem...

Pharma 4.0 is here, and it’s redefining what smart, compliant, and efficient drug manufacturing really looks like. This immersive session takes you inside Kindeva’s brand-new Bridgeton aseptic facility to see how technologies like automated fillers, electronic batch records, and VR modeling are transforming sterile fill-finish from the ground up. Through a virtual tour and real-world case study, discover how this 155,000 sq. ft. Annex 1-compliant site was designed, built, and operationalized in just one year to deliver more of what today’s drug developers need - speed, flexibility, and flawless execution from floor to ceiling.